Talcum Powder / Ovarian Cancer Marketing & Claimant Acquisition

The litigation landscape

The talcum powder litigation against Johnson & Johnson is consolidated in an MDL, reflecting the scale and complexity of claims alleging that asbestos-contaminated talc products caused ovarian cancer and mesothelioma. These are serious, life-altering diagnoses, and the volume of potential claimants who used J&J talc products over extended periods makes this one of the more substantive active mass torts in the plaintiff bar. The asbestos-contamination theory connects this litigation closely to the broader asbestos tort landscape — a comparison that experienced plaintiff attorneys will recognize as a signal of both the injury severity and the long latency periods involved.

Because mesothelioma and ovarian cancer can take years or decades to manifest after exposure, the claimant population spans a wide age range and geographic footprint, which is well-suited to Meta's targeting capabilities. Firms that move now on paid acquisition are positioning themselves ahead of any future consolidation or resolution activity that could tighten the intake window.

Who a campaign targets

• Primary target: Individuals diagnosed with ovarian cancer or mesothelioma who used Johnson & Johnson talcum powder products — particularly Baby Powder or Shower to Shower — for ten or more years.
• Use history: Long-term, regular perineal or body application is the core exposure pattern campaigns should screen for; duration of use is a key qualification signal.
• Diagnosis confirmation: Ovarian cancer or mesothelioma diagnosis is the anchor qualifier — campaigns and intake flows should be structured to confirm this early in the screening process.
• Borderline consideration: Peritoneal cancer cases without a confirmed talc-use history require closer attorney review before acceptance; campaigns can surface these leads, but intake teams should flag them for case-by-case evaluation rather than auto-qualifying.
• Comparable profile: Firms experienced with asbestos claimant intake will find the qualification logic familiar — long latency, serious diagnosis, and a traceable product-exposure history are the three pillars.

How MTAA runs Talcum Powder / Ovarian Cancer campaigns

The creative strategy for talcum powder campaigns centers on recognition and trust. The J&J brand is one of the most widely recognized consumer names in the country, and many women used these products as part of a daily hygiene routine for years or decades — often without any awareness of the asbestos-contamination allegations. Effective ad creative meets that audience where they are: acknowledging the familiarity of the product, surfacing the connection to ovarian cancer or mesothelioma in plain language, and prompting women (or their family members) to find out whether a diagnosis may be linked. Facebook and Instagram are particularly well-suited here because the core claimant demographic — women who used these products regularly over many years — is highly reachable through Meta's interest and demographic targeting layers.

On the intake side, this tort benefits from a relatively clean qualification structure: use history and diagnosis are the two primary gates, which allows for efficient pre-screening before a lead reaches your intake team. MTAA builds campaign-to-intake flows that front-load those two questions, reducing unqualified volume and improving the economics of your acquisition spend. Given the injury severity and the active MDL posture, this is a tort where lead quality and intake speed both matter — and where a well-structured paid social program can deliver a consistent, scalable claimant pipeline.